{
 "id": "eosinophilic-granulomatosis-with-polyangiitis",
 "name": "Eosinophilic granulomatosis with polyangiitis",
 "aliases": [
  "Eosinophilic granulomatosis with polyangiitis (EGPA)"
 ],
 "acronyms": [
  "EGPA"
 ],
 "bodySystem": "immune",
 "parent": null,
 "children": [],
 "edition": "2026-11",
 "merkleRoot": "006ab9a329709cbe7f56a0e1a7c4a02f897655cdfecf9ca34d199690095adcb6",
 "builtFrom": "program.status and program.eligibility facts, grouped by the condition registry",
 "counts": {
  "open": 0,
  "limited": 0,
  "waitlist": 0,
  "closed": 1
 },
 "funds": [
  {
   "fund": "Eosinophilic granulomatosis with polyangiitis (EGPA)",
   "organization": "TotalAssist (Patient Advocate Foundation copay funds)",
   "status": "closed",
   "dateOnPage": null,
   "awardLevelUsd": 7400,
   "insuranceTypes": [
    "Any health insurance"
   ],
   "pageSays": "The page lists the fund as Closed.",
   "readOn": "2026-11-08",
   "source": "https://totalassist.org/funds/"
  }
 ],
 "drugsWhoseLabelNamesThisCondition": [
  {
   "ingredient": "Benralizumab",
   "pages": [
    {
     "brand": "Fasenra",
     "url": "https://omnirx.org/medicines/fasenra"
    }
   ],
   "labelSentence": "... treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22da6aca1a-19ed-44a4-abb7-696c7d58b784%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Asthma Medication Assistance (Multiple Programs)",
     "url": "https://omnirx.org/assistance/asthma-medication-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "AZ&Me Prescription Savings Program",
     "url": "https://omnirx.org/assistance/astrazeneca-azandme",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": "limited",
     "statusRead": "2026-11-06"
    }
   ],
   "medicareNegotiatedPrice": null
  },
  {
   "ingredient": "Mepolizumab",
   "pages": [
    {
     "brand": "Nucala",
     "url": "https://omnirx.org/medicines/nucala"
    }
   ],
   "labelSentence": "The treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).",
   "labelContext": "indication",
   "labelSource": "https://api.fda.gov/drug/label.json?search=set_id:%22fefb887c-e4ac-431e-8893-e9d1a5a63fea%22&limit=1",
   "labelRead": "2026-11-10",
   "manufacturerPrograms": [
    {
     "name": "Asthma Medication Assistance (Multiple Programs)",
     "url": "https://omnirx.org/assistance/asthma-medication-assistance",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": null,
     "status": null,
     "statusRead": null
    },
    {
     "name": "GSK Patient Assistance Program (GSK ViiV Healthcare Patient Access Programs Foundation)",
     "url": "https://gskpaf.org/gsk/prescription-medicine-patient-assistance/",
     "programPageIsExternal": true,
     "inCurrentList": true,
     "note": null,
     "listKind": "List of eligible products (GSK prescription medicines)",
     "status": null,
     "statusRead": null
    }
   ],
   "medicareNegotiatedPrice": null
  }
 ],
 "fundsForRelatedCosts": [],
 "note": "Each status is what the fund page said on readOn. It is not an eligibility determination. We hold only the organizations we read; no fund here does not mean no fund exists.",
 "licence": "CC BY 4.0 for the OmniRx compilation"
}